Prostate cancer with small-cell morphology: An immunophenotypic subdivision

Scandinavian Journal of Urology and Nephrology

Volumn 39, Issue 6, 2005, Pages 455-463

  Petraki, Constantina ^a,b   Vaslamatzis, Michael ^a   Petraki, Kalliopi ^a   Revelos, Kyriakos ^a   Alevizopoulos, Nektarios ^a   Papanastasiou, Panagiotis ^a   Gregorakis, Alkiviadis ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Chemotherapy; Neuroendocrine differentiation; Prostate cancer; Small cell morphology

Indexed keywords

ANDROGEN RECEPTOR; BIOTIN; CISPLATIN; EPITHELIAL MEMBRANE ANTIGEN; ETOPOSIDE; PHOSPHATASE; PROSTATE SPECIFIC ANTIGEN; STREPTAVIDIN;

AGED; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

AGED; AGED, 80 AND OVER; ANTIGENS, CD57; BIOPSY; CARCINOMA, SMALL CELL; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 28444450516     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590500199855     Document Type: Article

References (44)

1. Oesterling JE, Hauzeur CG, Farrow GM. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 1992;147:804-7.
2. Rubenstein JH, Katin MJ, Managano MM, Dauphin J, Salenius SA, Dosoretz DE, et al. Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol 1997;20:376-80.
3. Helpap B, Koelermann J. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis. Virchows Arch 1999;434:385-91.
4. Ro JY, Tetu B, Ayala AG, Ordonez NG. Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer 1987;59:977-82.
5. Hodge GB, Carson CC. Oat cell carcinoma of lung masquerading as prostatic carcinoma. Urology 1985;25:69-70.
6. Abbas F, Civantos F, Benedetto P, Soloway MS. Small cell carcinoma of the bladder and prostate. Urology 1995;46:617-30.
7. Schwartz LH, LaTrenta LR, Bonaccio E, Kelly NK, Scher HI, Panicek DM. Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen level. Radiology 1998;208:735-8.
8. Schron DS, Gipson T, Mendelsohn G. The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study. Cancer 1984;53:2478-80.
9. Novak J, Hanus T, Dvoracek J. Small-cell carcinoma of the prostate. Cas Lek Cesk 1998;137:522-4.
10. Hindson DA, Knight LL, Ocker JM. Small-cell carcinoma of prostate. Transient complete remission with chemotherapy. Urology 1985;26:182-4.
11. Helpap B, Kollermann J, Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999;62:133-8.
12. Hashine K, Nakatsuji H, Karashima T, Sumiyoshi Y, Mandai K, Hata A. Small cell carcinoma of the prostate: a case report. Hinoyokika Kiyo 1998;44:607-10.
13. Zrara I, al Bouzidi A, Rimani M, Touiti D, Labraimi A, Ben Omar S. Small cell carcinoma of the prostate. A propos of a case. J Urol (Paris) 1996;102:188-90.
14. Raica M. Pathology and histochemistry of small cell carcinoma of the prostate. Rom J Morphol Embryol 1995;41:107-10.
15. Zachariah B, Casey L, Zahariah SB, Baekey P, Greenberg HM. Case report: brain metastasis from primary small cell carcinoma of the prostate. Am J Med Sci 1994;308:177-9.
16. Debras, Chautard D, Delva R. Small cell carcinoma of the prostate. Complete remission after chemotherapy: apropos of a case. Prog Urol 1994;4:569-71; discussion 572.
17. Bolton DM, Chiu ST, Clarke S, Angus D. Primary small cell carcinoma of the prostate: unusual modes of presentation. Aust N Z J Surg 1994;64:91-4.
18. Morikawa T, Kobayashi S, Yamadori I, Okino T, Ohmori M, Kurose M. Small cell carcinoma of the prostate. A case report. Int Urol Nephrol 1993;25:379-84.
19. Minguez R, Sempere A, Arellano R, Muyano JL, Sanz J, Fraga J, et al. Small cell (oat cell) carcinoma of the prostate. Presentation of a case and review of the literature. Actas Urol Esp 1992;16:518-22.
20. Niel C, Huys J, De Potter C. Small cell prostate cancer with bone marrow invasion - a case report. Acta Oncol 1992;31:595-6.
21. Hagood PG, Johnson FE, Bedrossian CW, Silverberg AB. Small cell carcinoma of the prostate. Cancer 1991;67:1046-50.
22. Yu DS, Chang SY, Wang J, Yang TH, Cheng CL, Lee SS, et al. Small cell carcinoma of the urinary tract. Br J Urol 1990;66:590-5.
23. Sarma DP, Weinbaecher TG. Small-cell carcinoma of the prostate. Urology 1989;33:332-5.
24. Epstein JI, Murphy WM. Diseases of the prostate gland and seminal vesicles. In: Murphy WM, editor. Urological pathology. Philadelphia, PA: WB Saunders; 1997. p. 148-241.
25. Sim SJ, Glassman AB, Ro JY, Lee JJ, Logothetis CJ, Liu FJ. Serum calcitonin in small cell carcinoma of the prostate. Ann Clin Lab Sci 1996;26:487-95.
26. Shulkes A, Fletcher DR, Rubinstein C, Ebeling PR, Martin TJ. Production of calcitonin gene related peptide, calcitonin and PTH-related protein by a prostatic adenocarcinoma. Clin Endocrinol (Oxf) 1991;34:387-93.
27. Pereira Arias JG, Astobieta Odriozola A, Prieto Ugidos N, Aurtenetxe Goiriena JJ, Bernuy Malfaz C. Inappropriate antidiuretic hormone secretion syndrome: a rare manifestation of prostatic adenocarcinoma. Arch Esp Urol 1995;48:1042-5.
28. Smith DC, Tucker JA, Trump DL. Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol 1992;10:499-505.
29. Tetu B, Ro JY, Ayala AG, Ordonez NG, Logothetis CJ, von Eschenbach AC. Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. Urology 1989;33:148-52.
30. Haukaas SA, Halvorsen OJ, Nygaard SJ, Paus E. Cushing's syndrome in prostate cancer. An aggressive course of prostatic malignancy. Urol Int 1999;63:126-9.
31. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 1996;28:98-106.
32. Christopher ME, Seftel AD, Sorenson K, Resnick MI. Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. J Urol 1991;146:382-8.
33. Valle J, von Boguslawsky K, Stenborg M, Andersson LC. Progression from adenocarcinoma to small cell carcinoma of the prostate with normalization of prostate-specific antigen (PSA) levels. Scand J Urol Nephrol 1996;30:509-12.
34. Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NE. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 1987;59:1803-9.
35. Di Sant'Agnese PA, Egevad L, Epstein JI, Helpap B, Humphrey PA, Montironi R, et al. Tumours of the prostate. Neuroendocrine tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. WHO classification: tumours of the urinary system and male genital organs. Lyon, France: IARC Press; 2004. p. 207-8.
36. Cheuk W, Chan JK. Thyroid transcription factor-1 is of limited value in practical distinction between pulmonary and extrapulmonary small cell carcinomas. Am J Surg Pathol 2001;25:545-6.
37. Erasmus CE, Verhagen WI, Wauters CA, Lindert EJ. Brain metastasis from prostate small cell carcinoma: not to be neglected. Can J Neurol Sci 2002;29:375-7.
38. Moore SR, Reinberg Y, Zhang G. Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 1992;39:411-6.
39. Cussenot O, Villette JM, Cochand-Priollet P, Berthon P. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumours. Prostate Suppl 1998;8:43-51.
40. Mackey JR, Au HJ, Hugh J, Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 1998;159:1624-9.
41. Papandreou CN, Daliani DD, Thall PF, Tu SM, Wang X, Reyes A, et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 2002;20:3072-80.
42. Alacreu JM, Ramirez MJ, Pontones Moreno JL, Valls Blasco F, Vera-Sempere FJ, Jimenez-Cruz JF. Small cell carcinoma of the prostate. Actas Urol Esp 2002;26:585-8.
43. Helpap B, Kloppel G. Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge. Virchows Arch 2002;440:241-8.
44. Helpap B. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer 2002;95:1415-20.